IBBQ:NSD-Invesco Nasdaq Biotechnology ETF (USD)

ETF | Others |

Last Closing

USD 22.5726

Change

-0.18 (-0.78)%

Market Cap

USD 0.03B

Volume

4.14K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

-1.55 (-0.78%)

USD 29.04B
ACWI iShares MSCI ACWI ETF

-0.23 (-0.20%)

USD 18.71B
IBIT iShares Bitcoin Trust

+0.40 (+1.09%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% ..

-0.04 (-0.19%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.11 (-0.20%)

USD 14.10B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 3.07B
IBTE iShares iBonds Dec 2024 Term T..

N/A

USD 2.79B
IBTF iShares iBonds Dec 2025 Term T..

-0.01 (-0.02%)

USD 2.33B
NVDL GraniteShares 2x Long NVDA Dai..

-6.03 (-7.07%)

USD 2.05B
USCL iShares Climate Conscious & Tr..

-0.07 (-0.11%)

USD 2.01B

ETFs Containing IBBQ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.12% 57% F 64% D
Dividend Return 0.20% 12% F 8% B-
Total Return 3.32% 55% F 63% D
Trailing 12 Months  
Capital Gain 6.47% 59% D- 66% D+
Dividend Return 0.86% 18% F 12% F
Total Return 7.34% 55% F 64% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -2.26% 35% F 39% F
Dividend Return -2.02% 31% F 36% F
Total Return 0.25% 20% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 10.59% 51% F 87% B+
Risk Adjusted Return -19.04% 33% F 31% F
Market Capitalization 0.03B 45% F 22% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.